More about

Myocardial Infarction

News
April 18, 2025
3 min read
Save

Cardiovascular-kidney-metabolic syndrome rose in US over 20 years

BOSTON — The prevalence of cardiovascular-kidney-metabolic syndrome has increased during the past 20 years among U.S. adults, with a drop in the number of adults with no risk factors, data show.

News
April 07, 2025
4 min read
Save

RSV may elevate risk for stroke, heart failure hospitalization

CHICAGO — Acute respiratory syncytial virus was associated with elevated incidence of cardiovascular events among older adults, specifically HF hospitalization and stroke, according to new research.

News
March 28, 2025
4 min read
Save

Cannabis use tied to elevated heart attack risk in younger adults

New research links regular cannabis use with heart attack and other adverse cardiovascular events in otherwise healthy adults aged 50 years and younger.

News
February 27, 2025
2 min read
Save

Early hyponatremia after starting thiazide associated with increased mortality risk

Patients who develop early hyponatremia after starting thiazide diuretics have a higher mortality risk than those with normal sodium levels, according to retrospective study data.

Learn the Heart

Part of the Healio Network

All ECG 56

News
February 19, 2025
2 min read
Save

Glomerular hyperfiltration may increase CVD risk for patients with type 2 diabetes

Glomerular hyperfiltration may increase CVD risks, including myocardial infarction and heart failure, for patients with type 2 diabetes, study data show.

Learn the Heart

Part of the Healio Network

All ECG 20

News
January 31, 2025
2 min read
Save

Osimertinib linked to more therapy-related cardiac events than other TKIs for NSCLC

Patients with EGFR-mutated non-small cell lung cancer treated with osimertinib experienced more cancer therapy-related cardiac events than those treated with other EGFR tyrosine kinase inhibitors.

News
January 22, 2025
3 min read
Save

Targeted therapies for breast cancer increase thrombosis risk

SAN DIEGO — The true incidence of thrombosis among people who received targeted therapy for breast cancer is significantly higher than reported in prior clinical trials, according to study results.

News
January 21, 2025
3 min read
Save

Study: GLP-1s ‘hold promise’ for treating a wide range of diseases and health outcomes

Glucagon-like peptide-1 receptor agonist use corresponded with risk reductions for dozens of diseases and adverse health outcomes, such as dementia and stroke, a new analysis published in Nature Medicine showed.

View more